ENSG00000196660


Homo sapiens

Features
Gene ID: ENSG00000196660
  
Biological name :SLC30A10
  
Synonyms : Q6XR72 / SLC30A10 / solute carrier family 30 member 10
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 1
Strand: -1
Band: q41
Gene start: 219685427
Gene end: 219958647
  
Corresponding Affymetrix probe sets: 220435_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000355893
Ensembl peptide - ENSP00000349018
NCBI entrez gene - 55532     See in Manteia.
OMIM - 611146
RefSeq - NM_018713
RefSeq Peptide - NP_061183
swissprot - Q6XR72
Ensembl - ENSG00000196660
  
Related genetic diseases (OMIM): 613280 - Hypermanganesemia with dystonia 1, 613280
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 slc30a10ENSDARG00000103983Danio rerio
 SLC30A10ENSGALG00000026727Gallus gallus
 Q3UVU3ENSMUSG00000026614Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
Q9Y6M5 / SLC30A1 / solute carrier family 30 member 1ENSG0000017038535
O14863 / SLC30A4 / solute carrier family 30 member 4ENSG0000010415417
Q99726 / SLC30A3 / solute carrier family 30 member 3ENSG0000011519416
Q9BRI3 / SLC30A2 / solute carrier family 30 member 2ENSG0000015801416
Q8IWU4 / SLC30A8 / solute carrier family 30 member 8ENSG0000016475616


Protein motifs (from Interpro)
Interpro ID Name
 IPR002524  Cation efflux protein
 IPR027469  Cation efflux transmembrane domain superfamily
 IPR036837  Cation efflux protein, cytoplasmic domain superfamily


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0006811 ion transport IEA
 biological_processGO:0006812 cation transport IEA
 biological_processGO:0006828 manganese ion transport IMP
 biological_processGO:0006829 zinc ion transport IEA
 biological_processGO:0007173 epidermal growth factor receptor signaling pathway IDA
 biological_processGO:0010043 response to zinc ion IBA
 biological_processGO:0043524 negative regulation of neuron apoptotic process IMP
 biological_processGO:0055085 transmembrane transport IEA
 biological_processGO:0061088 regulation of sequestering of zinc ion IBA
 biological_processGO:0070374 positive regulation of ERK1 and ERK2 cascade IDA
 biological_processGO:0071421 manganese ion transmembrane transport IDA
 biological_processGO:0071577 zinc ion transmembrane transport IEA
 biological_processGO:0071579 regulation of zinc ion transport IDA
 biological_processGO:1903427 negative regulation of reactive oxygen species biosynthetic process IDA
 biological_processGO:1904385 cellular response to angiotensin IDA
 biological_processGO:1905802 regulation of cellular response to manganese ion IDA
 biological_processGO:2000773 negative regulation of cellular senescence IDA
 cellular_componentGO:0005768 endosome IEA
 cellular_componentGO:0005769 early endosome IEA
 cellular_componentGO:0005794 Golgi apparatus IEA
 cellular_componentGO:0005886 plasma membrane IBA
 cellular_componentGO:0016020 membrane IEA
 cellular_componentGO:0016021 integral component of membrane IEA
 cellular_componentGO:0055037 recycling endosome IEA
 molecular_functionGO:0005384 manganese ion transmembrane transporter activity TAS
 molecular_functionGO:0005385 zinc ion transmembrane transporter activity IBA
 molecular_functionGO:0005515 protein binding IPI
 molecular_functionGO:0008324 cation transmembrane transporter activity IEA


Pathways (from Reactome)
Pathway description
Metal ion SLC transporters


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000007 Autosomal recessive inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in homozygotes. In the context of medical genetics, autosomal recessive disorders manifest in homozygotes (with two copies of the mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele)." [HPO:curators]
Show

 HP:0001260 Dysarthria "Dysarthric speech is a general description referring to a neurological speech disorder characterized by poor articulation. Depending on the involved neurological structures, dysarthria may be further classified as spastic, flaccid, ataxic, hyperkinetic and hypokinetic, or mixed." [HPO:curators]
Show

 HP:0001300 Parkinsonism 
Show

 HP:0001332 Dystonia "An abnormally increased muscular tone that causes fixed abnormal postures. There is a slow, intermittent twisting motion that leads to exaggerated turning and posture of the extremities and trunk." [HPO:curators]
Show

 HP:0001337 Tremor "An unintentional, oscillating to-and-fro muscle movement." [HPO:curators]
Show

 HP:0001394 Cirrhosis 
Show

 HP:0001410 Decreased liver function 
Show

 HP:0001901 Erythrocytosis 
Show

 HP:0002063 Rigidity 
Show

 HP:0002067 Bradykinesia "Bradykinesia literally means slow movement, and is used clinically to denote a slowness in the execution of movement (in contrast to hypokinesia, which is used to refer to slowness in the initiation of movement)." [HPO:curators]
Show

 HP:0002172 Postural instability 
Show

 HP:0002240 Hepatomegaly "An abnormal enlargment of the liver." [HPO:curators]
Show

 HP:0002313 Spastic paraparesis 
Show

 HP:0002910 Elevated transaminases "Elevations of the levels of SGOT and SGPT in the serum. SGOT (serum glutamic oxaloacetic transaminase) and SGPT (serum glutamic pyruvic transaminase) are transaminases primarily found in the liver and heart and are released into the bloodstream as the result of liver or heart damage. SGOT and SGPT are used clinically mainly as markers of liver damage." [HPO:curators]
Show

 HP:0003828 Variable expressivity 
Show

 HP:0007010 Poor fine motor coordination 
Show

 HP:0007141 Sensorimotor neuropathy 
Show

 HP:0025196 Increased total iron binding capacity "An elevation in the total-iron binding capacity, which measures how much serum iron is bound if an excess of radioactive iron is added. A high TIBC corresponds to a high transferrin concentration. The latent (or free) iron binding capacity is the difference between the TIBC and the measured serum iron, corresponding to the transferrin not bound to iron, i.e., free iron binding capacity." [PMID:3542299]
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
No match






 

1 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr